Abstract:Rationale: The transformation of fibroblasts into activated myofibroblasts is a critical step that results in cardiac fibrosis upon myocardial infarction (MI). Leucine-rich repeat-containing protein-8A (LRRC8A) is a multi-functional protein involved in cell survival, growth, and proliferation, whereas its role in regulating myofibroblast phenotypes and myocardial fibrosis remains unknown. Methods: Conditional myofibroblast-specific Lrrc8a knockout mouse models were established by crossing the Lrrc8aflox/flox mice with the tamoxifen-inducible periostin-Cre transgenic mice. The involvement of LRRC8A in regulating cardiac fibrosis post-MI and myofibroblast phenotypes induced by transforming growth factor-β1 (TGF-β1) was comprehensively evaluated. The mechanisms underlying LRRC8A regulation of myofibroblast phenotypes were determined by RNA sequencing-driven analysis followed by cause-effect experiments. Results: LRRC8A expression was significantly elevated in the fibrotic tissues and the fibroblasts isolated from the post-MI hearts. Compared with the wild-type (WT) littermates, the specific knockout of LRRC8A in myofibroblasts greatly attenuated myofibroblast transformation, fibrotic remodeling, and ventricular dysfunction after MI. Silencing of LRRC8A expression suppressed, whereas overexpression of LRRC8A enhanced, the pro-fibrotic myofibroblast phenotypes in isolated cardiac fibroblasts upon stimulation with TGF-β1. LRRC8A participated in TGF-β1-induced myofibroblast transformation via activating JAK2-STAT3 signaling. Furthermore, LRRC8A activated the JAK2-STAT3 pathway via its C-terminal leucine-rich repeat-domain (LRRD), directly interacting with growth factor receptor-bound protein 2 (GRB2), an adaptor protein associated with and necessary for tyrosine-phosphorylated JAK2. Conclusions: LRRC8A regulates myofibroblast transformation and cardiac fibrosis following MI. LRRC8A inhibition might be a promising strategy for cardiac fibrosis and heart failure.

LRTM1 promotes the differentiation of myoblast cells by negatively regulating the FGFR1 signaling pathway

Lrrc75b is A Novel Negative Regulator of C2c12 Myogenic Differentiation

LncRNA 4930581F22Rik promotes myogenic differentiation by regulating the ERK/MAPK signaling pathway

FGF13 Regulates Proliferation and Differentiation of Skeletal Muscle by Down-Regulating Spry1.

Lactoferrin Deficiency Impairs Proliferation of Satellite Cells via Downregulating the ERK1/2 Signaling Pathway

A feedback circuit between miR-133 and the ERK1/2 pathway involving an exquisite mechanism for regulating myoblast proliferation and differentiation

Ankrd1 inhibits the FAK/Rho-GTPase/F-actin pathway by downregulating ITGA6 transcriptional to regulate myoblast functions

LRRC8A critically regulates myofibroblast phenotypes and fibrotic remodeling following myocardial infarction

Myogenesis controlled by a long non-coding RNA 1700113A16RIK and post-transcriptional regulation

Extracellular Signal–Regulated Kinase 1/2 Mitogen-Activated Protein Kinase Pathway is Involved in Myostatin-Regulated Differentiation Repression

TLR4 activation inhibits the proliferation and osteogenic differentiation of skeletal muscle stem cells by downregulating LGI1

MiR-743a-5p regulates differentiation of myoblast by targeting Mob1b in skeletal muscle development and regeneration

ASAP1 and ARF1 regulate myogenic differentiation in rhabdomyosarcoma by modulating TAZ activity

VEGFB Promotes Myoblasts Proliferation and Differentiation Through VEGFR1-PI3K/Akt Signaling Pathway

Foxk1 Promotes Cell Proliferation and Represses Myogenic Differentiation by Regulating Foxo4 and Mef2.

miR-152 regulates the proliferation and differentiation of C2C12 myoblasts by targeting E2F3

The transcriptional regulator KLF15 is necessary for myoblast differentiation and muscle regeneration by activating FKBP5

CircLRRFIP1 Promotes the Proliferation and Differentiation of Chicken Skeletal Muscle Satellite Cells by Sponging the Mir-15 Family Via Activating AKT3-mTOR/p70S6K Signaling Pathway.

MicroRNA-664-5p Promotes Myoblast Proliferation and Inhibits Myoblast Differentiation by Targeting Serum Response Factor and Wnt1

Lmod3 promotes myoblast differentiation and proliferation via the AKT and ERK pathways

miR-9-5p promotes myogenic differentiation via the Dlx3/Myf5 axis